Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SRM pseudogene 1 (SRMP1, also known as dJ1057D4.1) is annotated as a pseudogene, a segment of DNA that resembles a gene but has lost its original function, likely due to mutation[1][2][4]. Pseudogenes are generally considered nonfunctional, though some can regulate the expression of their parental genes at the RNA level through mechanisms such as acting as competing endogenous RNAs or producing small interfering RNAs[2][3][4][5]. No evidence is available to suggest that SRMP1 is transcribed, translated, or has a regulatory or disease-related function. As a pseudogene, it is not recognized as a therapeutic target, and no drugs, biomarkers, or safety concerns are associated with it. The presence of the term "pseudogene" and the NCBI Gene report indicate it should not be confused with functional gene products or classical drug targets[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SRM pseudogene 1 (SRMP1).